TOP STORIES

• BUSINESS New Grad Hiring Down 3.3% at 55 Drug Makers, Sales Rep Opportunities Fall amid DX: Survey
  April 20, 2021

• REGULATORY MHLW to Revoke Approval of 12 Kobayashi Kako Products as Documents Fabricated
  April 19, 2021

• ORGANIZATION Scandals Making It Difficult to Recommend Generics to Members: Kyokai Kenpo Chair
  April 16, 2021

• REGULATORY Olumiant Up for PAFSC Review for COVID-19 on April 21, Combo Use with Veklury
  April 15, 2021

• BUSINESS Lilly Japan Set for Leading Spot in All Core Areas in 2025, “No Plan to Replicate” Redundancy Program: Chief
  April 14, 2021

• REGULATORY 11 APIs to Get NHI Price Listing on April 21, 17 Billion Yen Peak Sales Projected for Lilly’s Migraine Med
  April 14, 2021

• REGULATORY Kymriah to Face 4% Price Cut in 1st CEA-Based Price Tweak, Yescarta Too
  April 13, 2021

• BUSINESS Novo Japan Notches 10% Growth in 2020, President Proud of This Feat amid Market Decline
  April 13, 2021

• BUSINESS Maruho Aspires to Get Back on Growth Track on New Drug Launches: President
  April 12, 2021

• BUSINESS Kobayashi Kako’s Seima Factory Operations Still Halted Even after 60-Day Order Lifted
  April 12, 2021

• ORGANIZATION Wakayama Council Makes List of 500 Drugs Commonly Used in Region, Snubs Nichi-Iko/Kobayashi Kako Generics
  April 9, 2021

• BUSINESS Nichi-Iko Recalls 2 Products over Quality Issues Days after Biz Suspension Lifted
  April 9, 2021

• BUSINESS Teijin Pharma Set to Transform Biz, Weather Feburic Patent Cliff with Takeda’s DPP-4s
  April 8, 2021

• BUSINESS Astellas Ended Scholarship Donation to Clear Up Doubts on Inducing Prescriptions, No Major Issues Seen after 1 Year
  April 8, 2021

• BUSINESS Takeda Sees FY2021 as Inflection Year for Pipeline, 4 Potential Approvals from 6 Submission-Planned Assets
  April 7, 2021

• BUSINESS AstraZeneca Looks to Become Top Drug Maker in Japan by 2025
  April 7, 2021

• REGULATORY AMED to Set Up Council to Hone Academic Seeds with Industry Input
  April 7, 2021

• BUSINESS Daiichi Sankyo Looks to Rack Up Sales of 1.6 Trillion Yen in FY2025, 3 ADCs as Drivers
  April 6, 2021

• REGULATORY MHLW to Consider Ways to Address Listing Delays Linked to Off-Year Re-Pricing: Official
  April 6, 2021

• REGULATORY Nichi-Iko’s Toyama Plant Gets Back Online as Suspension Order Lifted
  April 6, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• 103
• …
• Next ›
• 最終 »